BP
AVNR

Ballentine Partners’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Ballentine Partners’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-30,000
Closed -$138K – 143
2013
Q2 		$138K Buy
+30,000
New +$138K 0.02% 121